Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

CORCEPT THERAPEUTICS is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP

Topics Stocks

January 05, 2026

CORCEPT THERAPEUTICS is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP

January 05, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) fell 4.5% in the morning session after the company’s stock faced continued selling pressure following the U.S. Food and Drug...

Why Corcept (CORT) Stock Is Trading Lower Today

January 05, 2026

Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations

Why Is CORT Stock Falling Today? ↗

December 31, 2025

Via Stocktwits

January 03, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations

January 03, 2026

Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Possible Securities Law Violations

In today's session, these stocks are experiencing unusual volume. ↗

January 02, 2026

Via Chartmill

January 02, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Possible Securities Law Violations

January 02, 2026

Nasdaq, S&P 500 Futures Point To Strong New-Year Open On Wall Street: Why TSLA, BIDU, SLV, STLA Are On Traders' Radar Today ↗

January 02, 2026

Via Stocktwits

Topics Stocks

Stocks making big moves yesterday: FuelCell Energy, Corcept, and PacBio

January 01, 2026

Check out the companies making headlines yesterday:

Kaplan Fox Announces an Investigation Into Corcept Therapeutics, Inc. (CORT) for Potential Securities Law Violations

January 01, 2026

Kaplan Fox Announces an Investigation Into Corcept Therapeutics, Inc. (CORT) for Potential Securities Law Violations

January 01, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

One of the company's key drugs won't be challenged by a competing medication anytime soon.

Why Xeris Biopharma Stock Zoomed 7% Higher on Wednesday ↗

December 31, 2025

Via The Motley Fool

Why Corcept Therapeutics Plummeted by 50% Today ↗

December 31, 2025

The final day of 2025 saw the company get a sharp "no" from a top regulator.

Via The Motley Fool

Why Corcept (CORT) Shares Are Falling Today

December 31, 2025

Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) fell 51.4% in the afternoon session after the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) rejecting...

Kaplan Fox & Kilsheimer LLP is Investigating Corcept Therapeutics, Inc. (CORT) for Potential Securities Law Violations

Here are the top movers in Wednesday's session. ↗

December 31, 2025

Via Chartmill

December 31, 2025

Kaplan Fox & Kilsheimer LLP is Investigating Corcept Therapeutics, Inc. (CORT) for Potential Securities Law Violations

December 31, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Top movers analysis in the middle of the day on 2025-12-31: top gainers and losers in today's session. ↗

December 31, 2025

Via Chartmill

The market is filled with gapping stocks in Wednesday's session. ↗

December 31, 2025

Via Chartmill

Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism

December 31, 2025

From Corcept Therapeutics Incorporated

Via Business Wire

3 Cash-Producing Stocks with Questionable Fundamentals

December 28, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) fell 4.7% in the afternoon session after investor anxiety mounted ahead of a key U.S. Food and Drug Administration (FDA) decision for its...

Why Corcept (CORT) Stock Is Trading Lower Today

December 23, 2025

Corcept has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 13.8% to $81.75 per share while the index has gained 13.9%.

Topics Artificial Intelligence

Corcept (CORT): Buy, Sell, or Hold Post Q3 Earnings?

December 16, 2025

Shares of biopharma company Corcept Therapeutics (NASDAQ:CORT) fell 9.2% in the afternoon session after investment bank UBS initiated coverage of the company with a Neutral rating.

Topics Stocks

Why Corcept (CORT) Stock Is Down Today

December 16, 2025

Corcept (CORT) Q3 2025 Earnings Call Transcript

Topics Artificial Intelligence Economy Supply Chain

Corcept (CORT) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Via The Motley Fool

Topics Earnings Intellectual Property

Corcept Therapeutics Inc (NASDAQ:CORT) Presents a Strong Growth and Technical Breakout Case ↗

November 22, 2025

Corcept Therapeutics (CORT) combines strong fundamentals, including robust revenue growth and a healthy balance sheet, with a positive technical breakout setup.

Via Chartmill

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut.